EP 3212234 A1 20170906 - PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN AND PPAR AGONISTS
Title (en)
PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN AND PPAR AGONISTS
Title (de)
PHARMAZEUTISCHE KOMBINATIONEN AUS SITAGLIPTIN UND PPAR-AGONISTEN
Title (fr)
COMBINAISONS PHARMACEUTIQUES DE SITAGLIPTINE ET D'AGONISTES DE PPAR
Publication
Application
Priority
- TR 201412671 A 20141030
- EP 2015074930 W 20151028
Abstract (en)
[origin: WO2016066666A1] A pharmaceutical combination comprising sitagliptin or a pharmaceutically acceptable salt thereof in combination with a PPAR dual agonist or a pharmaceutically acceptable salt.
IPC 8 full level
A61K 45/06 (2006.01); A61K 9/14 (2006.01); A61K 31/40 (2006.01); A61K 31/42 (2006.01); A61K 31/422 (2006.01); A61K 31/4985 (2006.01); A61K 31/538 (2006.01); A61P 3/10 (2006.01); A61P 5/50 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 9/0056 (2013.01); A61K 9/1676 (2013.01); A61K 9/2027 (2013.01); A61K 9/209 (2013.01); A61K 31/40 (2013.01); A61K 31/42 (2013.01); A61K 31/422 (2013.01); A61K 31/4985 (2013.01); A61K 31/538 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2017.12); A61P 5/50 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2016066666A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2016066666 A1 20160506; EP 3212234 A1 20170906; MA 40868 A 20170905
DOCDB simple family (application)
EP 2015074930 W 20151028; EP 15797263 A 20151028; MA 40868 A 20151027